Teva Pharmaceutical Industries Ltd. (TEVA)
39.41
-0.80
(-1.99%)
USD |
NYSE |
Oct 23, 16:00
39.39
-0.02
(-0.05%)
After-Hours: 20:00
Teva Pharmaceutical Industries Price to Book Value : 5.922 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 5.922 |
| October 22, 2026 | 6.042 |
| October 21, 2026 | 6.104 |
| October 20, 2026 | 6.138 |
| October 19, 2026 | 6.208 |
| October 16, 2026 | 6.236 |
| October 15, 2026 | 6.177 |
| October 14, 2026 | 6.119 |
| October 13, 2026 | 6.198 |
| October 12, 2026 | 6.186 |
| October 09, 2026 | 6.176 |
| October 08, 2026 | 5.898 |
| October 07, 2026 | 5.887 |
| October 06, 2026 | 5.880 |
| October 05, 2026 | 5.960 |
| October 02, 2026 | 5.94 |
| October 01, 2026 | 5.907 |
| September 30, 2026 | 5.950 |
| September 29, 2026 | 5.982 |
| September 28, 2026 | 5.842 |
| September 25, 2026 | 5.889 |
| September 24, 2026 | 6.044 |
| September 23, 2026 | 5.862 |
| September 22, 2026 | 5.938 |
| September 21, 2026 | 6.020 |
| Date | Value |
|---|---|
| September 18, 2026 | 5.857 |
| September 17, 2026 | 5.889 |
| September 16, 2026 | 5.790 |
| September 15, 2026 | 5.898 |
| September 14, 2026 | 5.818 |
| September 11, 2026 | 5.560 |
| September 10, 2026 | 5.462 |
| September 09, 2026 | 5.537 |
| September 08, 2026 | 5.524 |
| September 04, 2026 | 5.464 |
| September 03, 2026 | 5.503 |
| September 02, 2026 | 5.634 |
| September 01, 2026 | 5.438 |
| August 31, 2026 | 5.417 |
| August 28, 2026 | 5.476 |
| August 27, 2026 | 5.653 |
| August 26, 2026 | 5.698 |
| August 25, 2026 | 5.725 |
| August 24, 2026 | 5.549 |
| August 21, 2026 | 5.611 |
| August 20, 2026 | 5.531 |
| August 19, 2026 | 5.630 |
| August 18, 2026 | 5.497 |
| August 17, 2026 | 5.479 |
| August 14, 2026 | 5.525 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bristol Myers Squibb Co. | 5.628 |
| Merck & Co., Inc. | 8.552 |
| RedHill Biopharma Ltd. | 0.0192 |
| AstraZeneca PLC | 11.24 |
| Eli Lilly & Co. | 35.39 |
Price to Book Value Related Metrics
| PE Ratio | 66.27 |
| PS Ratio | 2.643 |
| Price to Free Cash Flow | 31.40 |
| Price | 39.41 |
| Earnings Yield | 1.51% |
| Market Cap | 45.91B |
| Operating PE Ratio | 14.07 |
| Normalized PE Ratio | 24.83 |